Neuronetics Inc logo

Neuronetics Inc

€ 2.40 (+0.76%) Sep 27
P/E:
At Loss
P/B:
0.94
Market Cap:
€ 66.84M ($ 63.90M)
Enterprise V:
€ 32.12M ($ 30.71M)
Volume:
-
Avg Vol (2M):
398.00
Also Trade In:
Volume:
-
Market Cap €:
66.84M
Market Cap $:
63.90M
PE Ratio:
At Loss
Avg Vol (2-Month):
398.00
Enterprise Value €:
32.12M
Enterprise Value $:
30.71M
PB Ratio:
0.94
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Name Current Vs Industry Vs History
Cash-To-Debt 1.84
Equity-to-Asset 0.56
Debt-to-Equity 0.58
Debt-to-EBITDA -1.13
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.8
Distress
Grey
Safe
Beneish M-Score -1.73
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 11.28
9-Day RSI 14.43
14-Day RSI 20.64
6-1 Month Momentum % 47.67
12-1 Month Momentum % -25.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.02
Quick Ratio 4.64
Cash Ratio 3.86
Days Inventory 164.68
Days Sales Outstanding 54.26
Days Payable 77.78

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.2

Financials (Next Earnings Date:2022-11-09 Est.)

FRA:NRC's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 53.347
EPS (TTM) (€) -1.262
Beta 1.81
Volatility % 69.06
14-Day RSI 20.64
14-Day ATR (€) 0.098318
20-Day SMA (€) 3.0541
12-1 Month Momentum % -25.23
52-Week Range (€) 1.963 - 5.694
Shares Outstanding (Mil) 27.02

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Neuronetics Inc Filings

Document Form Filing Date
No Filing Data

Neuronetics Inc Analysis

Share your research